December 27, 2024 10:53 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
I have lost a mentor and guide: Rahul Gandhi writes on Manmohan Singh's demise | Manmohan Singh left strong imprint on our economic policy over years: PM Modi | A rare leader who spoke softly but achieved monumental strides: Gautam Adani mourns Manmohan Singh's death | Instagram influencer and freelance RJ Simran Singh dies by suicide in Gurugram | Anna University sexual assault case: Accused is a DMK worker, claims BJP's Annamalai | Celebrities too responsible for crowd control: Telangana CM Revanth Reddy to Telugu filmdom amid Pushpa 2 stampede row | Boat capsizes off Calangute Beach in Goa; 1 killed, 20 rescued | Canada announces change to immigration system, likely to impact Indians seeking permanent residence | Azerbaijan Airlines tragedy: 32 passengers rescued, flight attempted several emergency landing before crashing | Man sets himself on fire near Parliament building; locals, police rush him to hospital
New England Journal of Medicine publishes new analyses confirming that Sanofi Pasteur's Vaccine candidate safely protects pre-adolescents to adults against Dengue

New England Journal of Medicine publishes new analyses confirming that Sanofi Pasteur's Vaccine candidate safely protects pre-adolescents to adults against Dengue

Jul 28, 2015, at 11:17 pm

Lyon, France, July 28 (IBNS) Sanofi Pasteur, the vaccines division of Sanofi, announced on Tuesday that new data analyses published in the New England Journal of Medicine (NEJM) provide a comprehensive picture of the potential public health impact of vaccinating endemic populations from pre-adolescence to adulthood against dengue.